- Home
- Results news
- Mardia Samyoung Capillary Tubes Company
- Q2 FY27 results
Mardia Samyoung Capillary Tubes Company Q2 FY27 results: net profit ₹0.98 crore vs ₹0.02 crore
Mardia Samyoung Capillary Tubes Company Ltd reported standalone revenue of ₹23.38 crore and a net profit of ₹0.98 crore for Q2 FY27. EBITDA was ₹1.29 crore at a 5.5% margin, while basic EPS was ₹0.12.
Key points
- Q2 FY27 revenue was ₹23.38 crore, up from ₹0.41 crore in Q2 FY26.
- Net profit was ₹0.98 crore, compared with ₹0.02 crore in Q2 FY26.
- EBITDA was ₹1.29 crore, with a margin of 5.5% against 4.2% a year earlier.
- Against Q1 FY27, revenue fell ₹1.46 crore and net profit fell ₹0.07 crore.
- H1 FY27 revenue was ₹48.22 crore and net profit was ₹2.03 crore, against ₹0.41 crore and a net loss of ₹0.21 crore in H1 FY26.
How did Mardia Samyoung Capillary Tubes Company perform in Q2 FY27?
Mardia Samyoung Capillary Tubes Company reported standalone revenue of ₹23.38 crore in Q2 FY27, up ₹22.97 crore from ₹0.41 crore in Q2 FY26. EBITDA rose ₹1.27 crore to ₹1.29 crore, while the EBITDA margin increased 1.3 percentage points to 5.5%. Profit before tax was ₹1.29 crore, and tax of ₹0.32 crore resulted in net profit of ₹0.98 crore, up ₹0.96 crore from ₹0.02 crore a year ago.
Against Q1 FY27, revenue fell ₹1.46 crore to ₹23.38 crore, EBITDA declined ₹0.13 crore to ₹1.29 crore and net profit fell ₹0.07 crore to ₹0.98 crore. The EBITDA margin eased 0.2 percentage points from 5.7% to 5.5%, while basic EPS declined ₹0.01 from ₹0.13 to ₹0.12. The results are standalone; no consolidated figures for the quarter were provided.
| ₹ crore | Q2 FY27 | Q1 FY27 | Q2 FY26 | YoY | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 23.38 | 24.84 | 0.41 | +5602.4% | −5.9% |
| Other income | 0 | 0 | 0 | ||
| Total expenses | 22.08 | 23.42 | 0.39 | +5561.5% | −5.7% |
| EBITDA | 1.29 | 1.42 | 0.02 | +6350.0% | −9.2% |
| EBITDA margin | 5.5% | 5.7% | 4.2% | +1.3 pp | −0.2 pp |
| Profit before tax | 1.29 | 1.42 | 0.02 | +6350.0% | −9.2% |
| Tax | 0.32 | 0.37 | 0 | −13.5% | |
| Net profit | 0.98 | 1.05 | 0.02 | +4800.0% | −6.7% |
| EPS (₹) | 0.12 | 0.13 | 0.02 | +500.0% | −7.7% |
EBITDA here is revenue from operations less operating costs (total expenses excluding finance costs and depreciation): before other income and exceptional items. Growth is shown only when both figures are positive. Source: Company's results filing (XBRL).
What changed in Mardia Samyoung Capillary Tubes Company's costs and profit?
Total expenses rose ₹21.69 crore from ₹0.39 crore in Q2 FY26 to ₹22.08 crore in Q2 FY27. Employee cost increased ₹0.06 crore to ₹0.07 crore, while other expenses rose ₹0.04 crore to ₹0.07 crore. Cost of materials, finance costs and depreciation were unchanged at ₹0 crore, and other income was unchanged at ₹0 crore.
There was no exceptional item in Q2 FY27. Tax expense was ₹0.32 crore against ₹0 crore in Q2 FY26, following profit before tax of ₹1.29 crore compared with ₹0.02 crore. Compared with Q1 FY27, total expenses fell ₹1.34 crore, employee cost rose ₹0.04 crore, other expenses rose ₹0.02 crore and tax fell ₹0.05 crore; the filing did not state reasons for these changes.
| ₹ crore | Q2 FY27 | Q2 FY26 | Change | Change % |
|---|---|---|---|---|
| Cost of materials | 0 | 0 | 0 | |
| Employee cost | 0.07 | 0.01 | +0.06 | +600.0% |
| Finance costs | 0 | 0 | 0 | |
| Depreciation | 0 | 0 | 0 | |
| Other expenses | 0.07 | 0.03 | +0.04 | +133.3% |
| Total expenses | 22.08 | 0.39 | +21.69 | +5561.5% |
| Other income | 0 | 0 | 0 | |
| Tax | 0.32 | 0 | +0.32 |
Source: Company's results filing (XBRL).
How did the first half of FY27 go?
In the first half of FY27, revenue was ₹48.22 crore, up ₹47.81 crore from ₹0.41 crore in H1 FY26. Profit before tax was ₹2.71 crore, compared with a loss of ₹0.21 crore in H1 FY26, while net profit was ₹2.03 crore against a net loss of ₹0.21 crore. Basic EPS was ₹0.26 in H1 FY27, compared with a loss of ₹0.30 in H1 FY26.
| ₹ crore | H1 FY27 | H1 FY26 | Change |
|---|---|---|---|
| Revenue from operations | 48.22 | 0.41 | +11661.0% |
| Profit before tax | 2.71 | −0.21 | turned to profit |
| Net profit | 2.03 | −0.21 | turned to profit |
| EPS (₹) | 0.26 | −0.30 |
Source: Company's results filing (XBRL).
What do the balance sheet and cash flow show?
For H1 FY27, operating cash flow was negative ₹12.01 crore, compared with negative ₹0.03 crore in H1 FY26. Investing cash flow was negative ₹0.01 crore against ₹0 crore, financing cash flow was positive ₹11.91 crore against positive ₹0.03 crore, and capital expenditure was ₹0.01 crore against ₹0 crore. The auditors said that certain balances remained subject to confirmation and reconciliation.
| ₹ crore | As of 30 September 2026 | As of 31 March 2026 |
|---|---|---|
| Total assets | 109.81 | 9.53 |
| Total equity | 107.76 | 9.39 |
| Borrowings | 0.06 | 0 |
| Cash and equivalents | 0.01 | 0.01 |
| Inventories | 1.02 | 0.58 |
| Trade receivables | 79.08 | 5.57 |
Source: Company's results filing (XBRL).
| ₹ crore | H1 FY27 | H1 FY26 |
|---|---|---|
| Cash from operations | −12.01 | −0.03 |
| Cash from investing | −0.01 | 0 |
| Cash from financing | 11.91 | 0.03 |
| Capital expenditure | 0.01 | 0 |
Source: Company's results filing (XBRL).
How has Mardia Samyoung Capillary Tubes Company done over the last 8 quarters?
Revenue reached its highest level in the supplied quarterly series at ₹24.84 crore in Q1 FY27 before easing to ₹23.38 crore in Q2 FY27. Q4 FY25 and Q1 FY26 recorded no revenue, while Q2 FY26 stood at ₹0.41 crore. Profit was highest in Q3 FY26 at ₹1.29 crore and lowest in Q1 FY26 at a loss of ₹0.23 crore; Q2 FY27 profit was ₹0.98 crore.
The EBITDA margin peaked at 15.3% in Q3 FY26 and was 5.5% in Q2 FY27, following 5.7% in Q1 FY27. The supplied series shows revenue and profit declining from Q1 FY27 to Q2 FY27, while the margin also moved lower. No quarter streak was provided.
How did Mardia Samyoung Capillary Tubes Company shares react?
After the filing, the stock was up 0.8% after five minutes, 0.8% after 15 minutes and 4.8% after 30 minutes. On the reaction day, it closed 5.0% above its pre-results close; by the next day's close, it was up 10.2% from that close, and by the fifth session, it was up 1.8%.
The industry median rose 0.7% on the reaction day, 1.7% by the next day's close and 3.9% by the fifth session. The stock's excess moves were 4.3 percentage points, 8.5 percentage points and negative 2.1 percentage points, respectively. Earlier reaction-day moves were negative 5.0% on 11 August 2026, positive 2.0% on 12 May 2026 and positive 2.0% on 12 August 2025.
| After the filing | Stock | Non - Ferrous Metals median |
|---|---|---|
| 5 minutes | +0.8% | |
| 15 minutes | +0.8% | |
| 30 minutes | +4.8% | |
| Reaction day | +5.0% | +0.7% |
| Next day | +10.2% | +1.7% |
| 5 days | +1.8% | +3.9% |
Minutes are measured from the price when the filing appeared; days from the previous close. Source: MarketPing price-reaction measurement.
| Results filed on | Stock on the reaction day |
|---|---|
| 11 August 2026 | −5.0% |
| 12 May 2026 | +2.0% |
| 12 August 2025 | +2.0% |
Source: MarketPing price-reaction measurement.
Quick answers
What was Mardia Samyoung Capillary Tubes Company's revenue in Q2 FY27?
Revenue from operations was ₹23.38 crore, up 5602.4% from ₹0.41 crore in Q2 FY26 (standalone).
Did Mardia Samyoung Capillary Tubes Company make a profit in Q2 FY27?
Yes. Net profit was ₹0.98 crore, against a net profit of ₹0.02 crore in Q2 FY26.
What was Mardia Samyoung Capillary Tubes Company's EPS in Q2 FY27?
Basic earnings per share were ₹0.12, against ₹0.02 in Q2 FY26.
How did Mardia Samyoung Capillary Tubes Company shares react to the Q2 FY27 results?
On the reaction day the stock moved +5.0% from the previous close; the median Non - Ferrous Metals stock moved +0.7%.
When did Mardia Samyoung Capillary Tubes Company announce its Q2 FY27 results?
On 26 October 2026, in a filing to the BSE.
Sources
- Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Pf SEBI To Be Held On Monday 26Th October, 2026 (BSE, 21 October 2026) · PDF
- Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. 26Th October, 2026 (BSE, 26 October 2026) · PDF
- Result For The Quarter Ended On 30Th September, 2026 (BSE, 26 October 2026) · PDF
How this was written: every figure in the tables and charts is calculated from the company’s filed results (XBRL) and MarketPing’s price measurements. The text is drafted with AI from those figures and the filings, and a checker removes any sentence carrying a number it cannot trace to them. How we write these.
This is information, not investment advice. MarketPing does not recommend buying or selling any security.